Author
Listed:
- Ceren Eyileten
(Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 02-097 Warsaw, Poland)
- Alex Fitas
(Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 02-097 Warsaw, Poland)
- Daniel Jakubik
(Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 02-097 Warsaw, Poland)
- Pamela Czajka
(Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 02-097 Warsaw, Poland)
- Anna Mróz
(Department of Physical Education, Józef Piłsudski University of Physical Education in Warsaw, 00-809 Warsaw, Poland)
- Anna Czajkowska
(Department of Tourism and Recreation, Józef Piłsudski University of Physical Education in Warsaw, 00-809 Warsaw, Poland)
- Katarzyna Witek
(Department of Tourism and Recreation, Józef Piłsudski University of Physical Education in Warsaw, 00-809 Warsaw, Poland)
- Wawrzyniec Bakalarski
(Department of Tourism and Recreation, Józef Piłsudski University of Physical Education in Warsaw, 00-809 Warsaw, Poland)
- Salvatore De Rosa
(Division of Cardiology, Department of Medical and Surgical Sciences, “Magna Graecia” University, 88100 Catanzaro, Italy)
- Marek Postuła
(Center for Preclinical Research and Technology CEPT, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 02-097 Warsaw, Poland)
- Łukasz A. Małek
(Department of Epidemiology, Cardiovascular Disease Prevention and Health Promotion, Institute of Cardiology, 04-628 Warsaw, Poland)
Abstract
The impact of long-term training on cardiovascular disease (CVD) is not clear. Carotid intima–media thickness (CIMT) test is recommended as a useful measure to diagnose the early stages of atherosclerosis. MicroRNAs (miRNAs) are altered due to endurance exercise and can be promising biomarkers of pathophysiological changes. We aimed to evaluate the association of circulating miRNAs with physical fitness and markers of atherosclerosis in ultra-marathon runners. Ultra-marathon runners had 28-fold upregulation of miR-125a-5p expressions compared to control individuals ( p = 0.002), whereas let-7e and miR-126 did not differ statistically between ultra-marathon runners and controls. In the ultra-marathon runners’ group, negative correlations were observed between VO 2 max/kg and relative expression of miR-125a-5p and miR-126 (r = −0.402, p = 0.028; r = −0.438, p = 0.032, respectively). Positive correlations were observed between CIMT and miR-125a-5p and miR-126 (r = 0.388, p = 0.050; r = 0.504, p = 0.023, respectively) in ultra-marathon runners. Individuals with the highest quartile of VO 2 max/kg had 23-fold lower miR-126 expression in comparison to subgroups with lower VO 2 max/kg ( p = 0.017). Our results may indicate that both miRNAs may serve as a biomarker for early pathological changes leading to atherosclerosis burden in athletes. Furthermore, the association between miRNAs and traditional risk factors for CVD indicate a possible use of these molecules as early biomarkers of future cardiovascular health.
Suggested Citation
Ceren Eyileten & Alex Fitas & Daniel Jakubik & Pamela Czajka & Anna Mróz & Anna Czajkowska & Katarzyna Witek & Wawrzyniec Bakalarski & Salvatore De Rosa & Marek Postuła & Łukasz A. Małek, 2021.
"Alterations in Circulating MicroRNAs and the Relation of MicroRNAs to Maximal Oxygen Consumption and Intima–Media Thickness in Ultra-Marathon Runners,"
IJERPH, MDPI, vol. 18(14), pages 1-13, July.
Handle:
RePEc:gam:jijerp:v:18:y:2021:i:14:p:7234-:d:589465
Download full text from publisher
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:14:p:7234-:d:589465. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.